Position in NVS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$7,836
+$199 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,549
of 1,603 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Indiana Trust & Investment Management Co holds $24,338,223 across 14 Drug Manufacturers - General names. NVS ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,321 | $15,977,608 | |
| 2 | JNJ |
Johnson & Johnson
|
12,463 | $3,165,228 | |
| 3 | ABBV |
AbbVie Inc.
|
9,867 | $2,482,931 | |
| 4 | AMGN |
Amgen Inc
|
2,065 | $747,777 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
11,769 | $678,129 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,996 | $641,986 | |
| 7 | PFE |
Pfizer Inc
|
14,124 | $340,105 | |
| 8 | AZN |
Astrazeneca PLC
|
420 | $79,640 |
All Filings in NVS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,836 | 50 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $7,637 | 50 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $6,893 | 50 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $9,618 | 75 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $9,075 | 75 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $8,361 | 75 | Shares | Sole | 2025-05-21 | |
| 2024-12-31 | $7,298 | 75 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $8,626 | 75 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $7,984 | 75 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $7,254 | 75 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $7,572 | 75 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $7,639 | 75 | Shares | Sole | 2023-10-10 | |
| No filing history on record for this holder in this stock. | ||||||